The Infectious Disease In vitro Diagnostics Market is projected to grow from US$ 45.69 billion in 2024 to US$ 76.71 billion by 2031, registering a CAGR of 7.7 percent during the forecast period 2025 to 2031. This steady growth highlights the increasing reliance on in vitro diagnostic solutions for effective disease detection and management across hospitals, diagnostic laboratories, and research...